Dr. Josef Penninger
Potential ‘Achilles’ heel’ of SARS-CoV-2 virus captured on video
Proteins known as lectins can bind to the spike protein on the SARS-CoV-2 virus and prevent it from accessing human cells, an international team of researchers led by the University of British Columbia’s Dr. Josef Penninger has demonstrated.
Apr 30, 2021
UBC scientist identifies a gene that controls thinness
Why can some people eat as much as they want, and still stay thin?
May 21, 2020
Webinar: UBC-led study gives hope for COVID-19 treatment
Scientists around the world, including Canada, are working tirelessly on the development and testing of new treatments and vaccines to help contain the current outbreak of COVID-19.
Apr 8, 2020
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
Apr 2, 2020
Pilot clinical trial in China to test UBC researcher’s findings as a targeted therapy for COVID-19
A University of British Columbia researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in China.
Feb 25, 2020